UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Biochemical pharmacology, ISSN 0006-2952, 09/2017, Volume 139, pp. 3 - 14
Porifera | Marine natural products | Drug discovery | Indans - adverse effects | Anti-Asthmatic Agents - therapeutic use | Humans | Drugs, Investigational - therapeutic use | Antineoplastic Agents - therapeutic use | Prodrugs - chemistry | Nonsteroidal Anti-Androgens - chemistry | Oligopeptides - therapeutic use | Nonsteroidal Anti-Androgens - therapeutic use | Sterols - adverse effects | Glycerol - analogs & derivatives | Porifera - chemistry | Benzhydryl Compounds - therapeutic use | Oligopeptides - chemistry | Anti-Asthmatic Agents - chemistry | Glycerol - therapeutic use | Indans - chemistry | Anti-Asthmatic Agents - pharmacology | Pyrrolidinones - adverse effects | Antimitotic Agents - adverse effects | Pyrrolidinones - therapeutic use | Antimitotic Agents - therapeutic use | Biological Products - isolation & purification | Biological Products - chemistry | Pyrrolidinones - isolation & purification | Cyclohexanols - therapeutic use | Oligopeptides - pharmacology | Anti-Asthmatic Agents - adverse effects | Cyclohexanols - adverse effects | Drugs, Investigational - adverse effects | Drugs, Investigational - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Oligopeptides - adverse effects | Indans - therapeutic use | Benzhydryl Compounds - chemistry | Drugs, Investigational - chemistry | Sterols - therapeutic use | Benzhydryl Compounds - adverse effects | Antineoplastic Agents - adverse effects | Cyclohexanols - chemistry | Nonsteroidal Anti-Androgens - adverse effects | Drug Design | Antineoplastic Agents - pharmacology | Glycerol - pharmacology | Aquatic Organisms - chemistry | Nonsteroidal Anti-Androgens - pharmacology | Sterols - pharmacology | Sterols - chemistry | Antineoplastic Agents - chemistry | Drug Discovery | Pyrrolidinones - chemistry | Prodrugs - adverse effects | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Antimitotic Agents - pharmacology | Benzhydryl Compounds - pharmacology | Prodrugs - therapeutic use | Prodrugs - pharmacology | Antimitotic Agents - chemistry | Chemical oceanography | Index Medicus
Journal Article
Pharmacoepidemiology and drug safety, ISSN 1053-8569, 06/2009, Volume 18, Issue 6, pp. 512 - 518
torsades de pointes | FDA | spontaneous reports | disproportionality | adverse drug reaction | Disproportionality | Adverse drug reaction | Spontaneous reports | Torsades de pointes | Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Life Sciences & Biomedicine | Science & Technology | Indans - adverse effects | Adverse Drug Reaction Reporting Systems | United States | Antipsychotic Agents - adverse effects | Humans | Databases, Factual - statistics & numerical data | Torsades de Pointes - chemically induced | Famotidine - adverse effects | Amiodarone - adverse effects | Piperidines - adverse effects | Anti-Bacterial Agents - adverse effects | Methadone - adverse effects | Antidepressive Agents - adverse effects | Cardiovascular Agents - adverse effects | Mitoxantrone - adverse effects | United States Food and Drug Administration | Index Medicus
Journal Article
Journal of Alzheimer's disease, ISSN 1387-2877, 2014, Volume 41, Issue 2, pp. 615 - 631
rivastigmine | memantine | safety | donepezil | meta-analysis | systematic review | Alzheimer's disease | galantamine | efficacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Indans - adverse effects | Phenylcarbamates - therapeutic use | Humans | Alzheimer Disease - drug therapy | Nootropic Agents - therapeutic use | Phenylcarbamates - adverse effects | Nootropic Agents - adverse effects | Indans - therapeutic use | Randomized Controlled Trials as Topic | Cholinesterase Inhibitors - administration & dosage | Galantamine - therapeutic use | Piperidines - therapeutic use | Rivastigmine | Piperidines - adverse effects | Galantamine - adverse effects | Memantine - therapeutic use | Memantine - adverse effects | Index Medicus
Journal Article
The lancet respiratory medicine, ISSN 2213-2600, 2013, Volume 1, Issue 1, pp. 51 - 60
Pulmonary/Respiratory | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - therapeutic use | Indans - adverse effects | Sympathomimetics - administration & dosage | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Male | Indans - therapeutic use | Quinolones - adverse effects | Quinolones - therapeutic use | Female | Indans - administration & dosage | Glucocorticoids - adverse effects | Sympathomimetics - adverse effects | Glycopyrrolate - adverse effects | Sympathomimetics - therapeutic use | Double-Blind Method | Drug Administration Schedule | Glycopyrrolate - therapeutic use | Administration, Inhalation | Albuterol - analogs & derivatives | Treatment Outcome | Glycopyrrolate - analogs & derivatives | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Albuterol - therapeutic use | Androstadienes - therapeutic use | Fluticasone-Salmeterol Drug Combination | Androstadienes - adverse effects | Albuterol - adverse effects | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Index Medicus
Journal Article
5.
Full Text
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs
Canadian Medical Association journal, ISSN 0008-4409, 04/2003, Volume 168, Issue 9, pp. 1133 - 1137
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Indans - adverse effects | Raloxifene Hydrochloride - adverse effects | Humans | Heptanoic Acids - adverse effects | Newspapers as Topic | Bibliometrics | Drug-Related Side Effects and Adverse Reactions | Acetamides - adverse effects | Pyrroles - adverse effects | Patient Education as Topic | Pyrazoles | Consumer Product Safety | Drug Industry | Celecoxib | Disclosure | Drug Prescriptions | Anticholesteremic Agents - adverse effects | Atorvastatin Calcium | Canada | Oseltamivir | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Antiviral Agents - adverse effects | Piperidines - adverse effects | Estrogen Antagonists - adverse effects | Cholinesterase Inhibitors - adverse effects | Sulfonamides - adverse effects | Advertising as Topic | Prescription drugs | Media coverage | Index Medicus | Abridged Index Medicus | Research
Journal Article
Lancet neurology, ISSN 1474-4422, 2014, Volume 13, Issue 11, pp. 1092 - 1099
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Indans - adverse effects | Receptors, Serotonin - physiology | Benzylamines - adverse effects | Follow-Up Studies | Humans | Male | Indans - therapeutic use | Alzheimer Disease - diagnosis | Serotonin Antagonists - adverse effects | Aged, 80 and over | Female | Alzheimer Disease - psychology | Cognition Disorders - psychology | Double-Blind Method | Alzheimer Disease - drug therapy | Nootropic Agents - therapeutic use | Serotonin Antagonists - therapeutic use | Treatment Outcome | Cognition Disorders - drug therapy | Nootropic Agents - adverse effects | Cognition Disorders - diagnosis | Indoles - adverse effects | Piperidines - therapeutic use | Piperidines - adverse effects | Indoles - therapeutic use | Aged | Benzylamines - therapeutic use | Index Medicus
Journal Article
Psychopharmacology, ISSN 0033-3158, 6/2015, Volume 232, Issue 11, pp. 1859 - 1866
Neurosciences | Xanomeline | Biomedicine | Muscarinic | Donepezil | Side-effects | Cognition | Pharmacology/Toxicology | Acetylcholinesterase | Psychiatry | Alzheimer’s | Alzheimer's | Pharmacology & Pharmacy | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Muscarinic Agonists - pharmacology | Humans | Male | Macaca mulatta | Piperidines - pharmacology | Receptor, Muscarinic M1 - drug effects | Attention - drug effects | Female | Problem Solving - drug effects | Thiadiazoles - pharmacology | Piperidines - toxicity | Quinolizines - toxicity | Salivation - drug effects | Defecation - drug effects | Alzheimer Disease - drug therapy | Quinolizines - pharmacology | Cognition - drug effects | Neuropsychological Tests | Thiadiazoles - toxicity | Orientation - drug effects | Animals | Pyridines - toxicity | Indans - toxicity | Aged | Pyridines - pharmacology | Appetitive Behavior - drug effects | Indans - pharmacology | Research | Drug therapy | Alzheimer's disease | Side effects | Alzheimers disease | Monkeys & apes | Psychopharmacology | Animal cognition | Index Medicus
Journal Article
Thorax, ISSN 0040-6376, 04/2015, Volume 70, Issue 4, pp. 311 - 319
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Bronchodilator Agents - therapeutic use | Indans - adverse effects | Ethanolamines - adverse effects | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Ethanolamines - administration & dosage | Indans - therapeutic use | Vital Capacity - drug effects | Quinolones - adverse effects | Adrenergic beta-2 Receptor Agonists - adverse effects | Quinolones - therapeutic use | Scopolamine Derivatives - administration & dosage | Adrenergic beta-2 Receptor Agonists - therapeutic use | Female | Indans - administration & dosage | Bronchodilator Agents - adverse effects | Scopolamine Derivatives - therapeutic use | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Glycopyrrolate - adverse effects | Double-Blind Method | Drug Administration Schedule | Glycopyrrolate - therapeutic use | Treatment Outcome | Glycopyrrolate - analogs & derivatives | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Quality of Life | Adrenergic beta-2 Receptor Agonists - administration & dosage | Ethanolamines - therapeutic use | Aged | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Care and treatment | Analysis | Formoterol | Indacaterol | Dosage and administration | Diagnosis | Quality of life | Index Medicus | 1506 | Chronic Obstructive Pulmonary Disease | COPD Pharmacology
Journal Article
Journal of Alzheimer's disease, ISSN 1387-2877, 2013, Volume 35, Issue 2, pp. 349 - 361
behavioral and psychological symptoms of dementia | Activities of daily living | memantine | meta-analysis | cholinesterase inhibitors | Alzheimer's disease | cognition disorders | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Indans - adverse effects | Neuroprotective Agents - therapeutic use | Humans | Middle Aged | Male | Indans - therapeutic use | Rivastigmine | Cognition - physiology | Female | Behavior | Neuroprotective Agents - adverse effects | Alzheimer Disease - psychology | Disability Evaluation | Data Interpretation, Statistical | Phenylcarbamates - therapeutic use | Alzheimer Disease - drug therapy | Phenylcarbamates - adverse effects | Treatment Outcome | Disease Progression | Randomized Controlled Trials as Topic | Neuropsychological Tests | Galantamine - therapeutic use | Piperidines - therapeutic use | Piperidines - adverse effects | Cholinesterase Inhibitors - adverse effects | Galantamine - adverse effects | Aged | Cholinesterase Inhibitors - therapeutic use | Memantine - therapeutic use | Memantine - adverse effects | Index Medicus
Journal Article
The lancet respiratory medicine, ISSN 2213-2600, 2013, Volume 1, Issue 3, pp. 199 - 209
Pulmonary/Respiratory | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Indans - adverse effects | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Dose-Response Relationship, Drug | Quinolones - adverse effects | Scopolamine Derivatives - administration & dosage | Female | Indans - administration & dosage | Bronchodilator Agents - adverse effects | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Glycopyrrolate - adverse effects | Severity of Illness Index | Pulmonary Disease, Chronic Obstructive - diagnosis | Double-Blind Method | Respiratory Function Tests - methods | Administration, Inhalation | Treatment Outcome | Glycopyrrolate - analogs & derivatives | Disease Progression | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Respiratory System - drug effects | Respiratory System - physiopathology | Aged | Drug Monitoring | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Index Medicus
Journal Article
The Annals of pharmacotherapy, ISSN 1060-0280, 11/2015, Volume 49, Issue 11, pp. 1197 - 1206
RIVASTIGMINE | DEMENTIA | METAANALYSIS | ALZHEIMERS-DISEASE | RISK | PREVALENCE | pharmacovigilance | Journal Article | DONEPEZIL | adverse drug reactions | Research Support, Non-U.S. Gov't | NATIONWIDE | cholinesterase inhibitors | GALANTAMINE | VigiBase | FRENCH PHARMACOVIGILANCE DATABASE | Alzheimer's disease | Alzheimer’s disease | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Indans - adverse effects | Medication Errors | World Health Organization | Adverse Drug Reaction Reporting Systems | Rivastigmine - adverse effects | Europe | Humans | Alzheimer Disease - drug therapy | Drug-Related Side Effects and Adverse Reactions - etiology | Male | Pharmacovigilance | North America | Piperidines - adverse effects | Aged, 80 and over | Cholinesterase Inhibitors - adverse effects | Female | Galantamine - adverse effects | Aged | Index Medicus | Life Sciences | Human health and pathology
Journal Article